Bromley Tells Congress Science Must Bolster U.S. Leadership

WASHINGTON—Members of Congress have rolled out the welcome mat for Allan Bromley the president’s new science adviser and director of the Office of Science and Technology Policy. But their enthusiastic greeting also has focused attention on the many difficult science-based problems facing the country. The issues aren’t new; among others, they include setting priorities for science, improving science education in elementary and secondary schools, replacing aging university equ

Written byJeffrey Mervis
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

WASHINGTON—Members of Congress have rolled out the welcome mat for Allan Bromley the president’s new science adviser and director of the Office of Science and Technology Policy. But their enthusiastic greeting also has focused attention on the many difficult science-based problems facing the country.

The issues aren’t new; among others, they include setting priorities for science, improving science education in elementary and secondary schools, replacing aging university equipment and facilities, restoring the balance between civilian and military research, and translating discoveries into commercial products. And the Bush administration doesn’t have any magical answers, especially for those projects that require additional funds. But legislators seem pleased with Bromley’s opinions on a range of topics, and they view his arrival as an opportunity for a fresh assault on them.

“It’s a real pleasure to have an OSTP director who’s not an apologist for SDI,” said Rep. Sherwood Boehiert (R-N.Y) in a reference ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies